NMRA
Neumora Therapeutics, Inc.
0.5253$
+5.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 96.5% | 96.4% | 98.4% | 98.5% | 98.9% | 99.1% | 99.3% | 99.6% | 99.6% | 99.7% | 99.7% | 99.7% | |
| 75.7% | 75.4% | 40.6% | 37.3% | 78.2% | 44.8% | 49.4% | 55.6% | 72.6% | 95.5% | 95.6% | 93.3% | |
| 93.5% | 91.5% | 93.9% | 91.9% | 96.8% | 97.0% | 97.1% | 97.2% | 96.5% | 95.5% | 95.6% | 93.3% | |
| 0.1% | 0.2% | 0.2% | 0.4% | – | – | – | – | – | – | – | – | |
| -0.1% | – | – | – | – | – | – | – | – | – | – | – | |
| 5.9% | 5.5% | 5.7% | 5.7% | 9.0% | 9.4% | 11.1% | 18.3% | 25.7% | 45.6% | 54.1% | 64.5% | |
| 5.3% | 5.1% | 5.5% | 5.7% | 9.0% | 9.4% | 11.1% | 9.5% | 14.5% | 17.0% | 19.6% | 22.2% | |
| 0.6% | 0.7% | 0.8% | 0.9% | 0.8% | 0.6% | 0.4% | 0.1% | 0.1% | 0.1% | 0.2% | 0.2% | |
| 0.4% | 0.1% | 0.3% | 0.3% | 1.7% | 1.0% | 0.4% | 0.3% | 0.3% | 1.8% | 3.3% | 3.3% | |
| – | – | – | – | – | – | – | 8.7% | 11.0% | 28.5% | 34.4% | 42.2% | |
| 94.1% | 94.5% | 94.3% | 94.3% | 91.0% | 90.6% | 88.9% | 81.7% | 74.3% | 54.4% | 45.9% | 35.5% | |
| -109.2% | -141.8% | -168.2% | -201.7% | -252.0% | -298.8% | -395.4% | -477.1% | -632.4% | -619.8% | -804.3% | -1,022.5% | |
| 29.2% | 32.0% | 35.1% | 39.3% | 45.3% | 50.8% | 62.9% | 72.2% | 91.0% | 85.5% | 116.9% | 147.8% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.